Pfizer announces new cost cutting program
Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched …
Pharmaceuticals
Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. The Nasdaq edged lower Tuesday, …
FDA approves Amgen small cell lung cancer treatment
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly …
Novavax stock jumps on Sanofi Covid vaccine deal
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters Shares of Novavax jumped as much as 50% on Monday …
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Arthur Allen | (TNS) KFF Health News When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician …
Moderna says RSV vaccine FDA approval delayed to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end …
Novavax and Sanofi to commercialize Covid vaccine, develop combo shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. …
AstraZeneca to withdraw Covid vaccine worldwide, citing drop in demand
In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images …
Generative AI will be designing new drugs on its own in near future
Eli Lilly chief information and digital officer Diogo Rau was recently involved in some experiments in the office, but not the typical drug research work that you might expect to …
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Shares of Danish pharmaceutical giant Novo Nordisk slid 4% on Friday, extending a 2.7% loss on Thursday as analysts pored over the details of the firm’s first-quarter results and monitored a potential rival …